Johnson & Johnson
(BSP:JNJB34)
R$
60.12
0 (0%)
Market Cap: 2.18 Til
Enterprise Value: 2.27 Til
PE Ratio: 24.52
PB Ratio: 5.08
GF Score: 76/100 Johnson & Johnson at JPMorgan Healthcare Conference Transcript
Jan 09, 2023 / 05:45PM GMT
Release Date Price:
R$61.32
(-2.29%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat with Joaquin Duato, Chairman and CEO of J&J today.
So Joaquin, happy new year.
Joaquin Duato
Johnson & Johnson - Chairman & CEO
Thank you.
Questions & Answers
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
And thanks for joining us. I thought I might just kick off the conversation. You're about a year into the CEO role, and I'd love to just hear some of your top priorities for the company as we think about 2023 and beyond and kind of what you're most focused on in the role right now.
Joaquin Duato
Johnson & Johnson - Chairman & CEO
Thank you, Chris, and thank you for inviting us, Johnson & Johnson, to participate once again in the conference.
So the overarching goal for Johnson &
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot